E-LIB Suche - Ergebnisse für: Lusque, A.

1

7P Trastuzumab deruxtecan (T-DXd) for advanced breast cance..:

Dieras, V.C. ; André, F. ; Lusque, A....
ESMO Open. 9 (2024) - p. 103016 , 2024

Link: https://doi.org/10.1016/..

2

Incidence and outcome of brain and/or leptomeningeal metast..:

Epaillard, N. ; Lusque, A. ; Jacot, W....
ESMO Open. 9 (2024) 5 - p. 103447 , 2024

Link: https://doi.org/10.1016/..

3

Cytopénies auto-immunes associées aux hémopathies lymphoïde..:

Zadro, Y. ; Lusque, A. ; Graveleau, J....
La Revue de Médecine Interne. 44 (2023) - p. A358 , 2023

Link: https://doi.org/10.1016/..

4

217P Incidence and outcome of brain and/or leptomeningeal m..:

Epaillard, N. ; Lusque, A. ; Jacot, W....
ESMO Open. 8 (2023) 1 - p. 101406 , 2023

Link: https://doi.org/10.1016/..

5

Efficacy of front-line treatment for hormone receptor-posit..:

Frenel, J.-S. ; Lusque, A. ; Delaloge, S....
British Journal of Cancer. , 2023

Link: https://doi.org/10.1038/..

6

OC-0091 Brainstem toxicity after proton or photon therapy i..:

Dalmasso, C. ; Alapetite, C. ; Bolle, S....
Radiotherapy and Oncology. 170 (2022) - p. S66-S67 , 2022

Link: https://doi.org/10.1016/..

7

Traitement du PTI et de l'AHAI associés aux hémopathies lym..:

Zadro, Y. ; Cougoul, P. ; Dion, J....
La Revue de Médecine Interne. 43 (2022) - p. A405 , 2022

Link: https://doi.org/10.1016/..

8

Brainstem toxicity after proton or photon therapy in childr..:

Dalmasso, C. ; Alapetite, C. ; Bolle, S....
International Journal of Radiation Oncology*Biology*Physics. 114 (2022) 5 - p. 1070-1071 , 2022

Link: https://doi.org/10.1016/..

9

Prophylactic nipple-sparing mastectomy with immediate breas..:

Houvenaeghel, G ; Cohen, M ; Dammacco, M A...
British Journal of Surgery. 108 (2021) 3 - p. 296-301 , 2021

Link: https://doi.org/10.1093/..

10

Tolerance and efficacy of dose escalation using IMRT combin..:

Modesto, A. ; Dalmasso, C. ; Lusque, A....
Cancer/Radiothérapie. 24 (2020) 2 - p. 88-92 , 2020

Link: https://doi.org/10.1016/..

11

Tumour and pelvic lymph node metabolic activity on FDG-PET/..:

Martinez, A. ; Voglimacci, M. ; Lusque, A....
European Journal of Nuclear Medicine and Molecular Imaging. 47 (2020) 5 - p. 1252-1260 , 2020

Link: https://doi.org/10.1007/..

12

Efficacité et tolérance de la radiothérapie en conditions s..:

Molinier, V. ; Izar, F. ; Lusque, A....
Cancer/Radiothérapie. 23 (2019) 6-7 - p. 804 , 2019

Link: https://doi.org/10.1016/..

13

Alternative methodological approach to randomized trial for..:

Filleron, T. ; Lusque, A. ; Dalenc, F....
Contemporary Clinical Trials. 68 (2018) - p. 109-115 , 2018

Link: https://doi.org/10.1016/..

14

Traitement médical ou chirurgical des cancers de l'orophary..:

Modesto, A. ; Galissier, T. ; Lusque, A....
Cancer/Radiothérapie. 21 (2017) 6-7 - p. 690 , 2017

Link: https://doi.org/10.1016/..

15

Prévalence des effets indésirables thyroïdiens chez les pat..:

Campredon, P. ; Bigay-Game, L. ; Mouly, C....
Annales d'Endocrinologie. 78 (2017) 4 - p. 234 , 2017

Link: https://doi.org/10.1016/..